Novocure Other Operating Expenses vs Income Tax Expense Analysis

NVCR Stock

USD 21.51 0.66 2.98%

Novocure financial indicator trend analysis is infinitely more than just investigating Novocure recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Novocure is a good investment. Please check the relationship between Novocure Other Operating Expenses and its Income Tax Expense accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novocure. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Novocure Stock, please use our How to Invest in Novocure guide.

Other Operating Expenses vs Income Tax Expense

Other Operating Expenses vs Income Tax Expense Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Novocure Other Operating Expenses account and Income Tax Expense. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Novocure's Other Operating Expenses and Income Tax Expense is 0.46. Overlapping area represents the amount of variation of Other Operating Expenses that can explain the historical movement of Income Tax Expense in the same time period over historical financial statements of Novocure, assuming nothing else is changed. The correlation between historical values of Novocure's Other Operating Expenses and Income Tax Expense is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Operating Expenses of Novocure are associated (or correlated) with its Income Tax Expense. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Income Tax Expense has no effect on the direction of Other Operating Expenses i.e., Novocure's Other Operating Expenses and Income Tax Expense go up and down completely randomly.

Correlation Coefficient

0.46

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Novocure. It is also known as Novocure overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Income Tax Expense

Most indicators from Novocure's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Novocure current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novocure. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Novocure Stock, please use our How to Invest in Novocure guide.As of 05/17/2024, Selling General Administrative is likely to drop to about 87.6 M. In addition to that, Tax Provision is likely to drop to about 9.1 M

	2021	2022	2023	2024 (projected)
Interest Expense	3.4M	3.3M	3.3M	3.2M
Depreciation And Amortization	10.3M	10.6M	11.0M	7.8M

Interest Expense Depreciation And Amortization

Novocure fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross
Total Assets		0.93	-0.45	0.89	0.93	0.65	0.95	0.8	0.91	-0.77	0.88	0.51	0.82	0.91	0.93	0.93	1.0	0.91	0.71	0.99	0.93	0.78	0.61	0.94	0.92	0.64
Short Long Term Debt Total	0.93		-0.54	0.98	0.82	0.62	0.83	0.94	0.98	-0.88	0.98	0.44	0.95	0.99	0.99	1.0	0.92	0.85	0.74	0.92	1.0	0.78	0.57	0.91	1.0	0.83
Other Current Liab	-0.45	-0.54		-0.55	-0.39	0.15	-0.44	-0.62	-0.52	0.35	-0.62	-0.25	-0.61	-0.52	-0.5	-0.54	-0.47	-0.26	-0.21	-0.47	-0.53	-0.16	0.22	-0.35	-0.54	-0.53
Total Current Liabilities	0.89	0.98	-0.55		0.76	0.63	0.79	0.97	0.96	-0.93	0.99	0.41	0.98	0.99	0.98	0.98	0.87	0.83	0.73	0.87	0.98	0.81	0.54	0.91	0.99	0.89
Total Stockholder Equity	0.93	0.82	-0.39	0.76		0.58	0.97	0.68	0.78	-0.57	0.77	0.58	0.7	0.82	0.84	0.82	0.95	0.83	0.52	0.92	0.82	0.59	0.56	0.81	0.81	0.5
Other Liab	0.65	0.62	0.15	0.63	0.58		0.54	0.49	0.59	-0.7	0.55	0.4	0.51	0.65	0.67	0.63	0.61	0.83	0.66	0.59	0.64	0.75	0.57	0.75	0.64	0.4
Net Tangible Assets	0.95	0.83	-0.44	0.79	0.97	0.54		0.74	0.78	-0.63	0.8	0.64	0.76	0.84	0.85	0.83	0.96	0.79	0.54	0.92	0.83	0.65	0.61	0.85	0.83	0.59
Property Plant And Equipment Net	0.8	0.94	-0.62	0.97	0.68	0.49	0.74		0.91	-0.9	0.98	0.39	1.0	0.95	0.94	0.93	0.79	0.7	0.64	0.78	0.94	0.75	0.5	0.84	0.95	0.96
Net Debt	0.91	0.98	-0.52	0.96	0.78	0.59	0.78	0.91		-0.89	0.95	0.25	0.92	0.95	0.96	0.98	0.9	0.84	0.72	0.93	0.98	0.81	0.55	0.91	0.98	0.79
Retained Earnings	-0.77	-0.88	0.35	-0.93	-0.57	-0.7	-0.63	-0.9	-0.89		-0.89	-0.24	-0.91	-0.88	-0.88	-0.88	-0.73	-0.78	-0.71	-0.75	-0.88	-0.93	-0.56	-0.92	-0.89	-0.88
Accounts Payable	0.88	0.98	-0.62	0.99	0.77	0.55	0.8	0.98	0.95	-0.89		0.42	0.99	0.98	0.98	0.98	0.87	0.79	0.68	0.87	0.98	0.76	0.52	0.88	0.99	0.9
Cash	0.51	0.44	-0.25	0.41	0.58	0.4	0.64	0.39	0.25	-0.24	0.42		0.41	0.5	0.49	0.43	0.52	0.43	0.39	0.39	0.44	0.22	0.33	0.4	0.44	0.32
Non Current Assets Total	0.82	0.95	-0.61	0.98	0.7	0.51	0.76	1.0	0.92	-0.91	0.99	0.41		0.97	0.95	0.95	0.81	0.72	0.66	0.8	0.95	0.76	0.51	0.86	0.96	0.95
Non Currrent Assets Other	0.91	0.99	-0.52	0.99	0.82	0.65	0.84	0.95	0.95	-0.88	0.98	0.5	0.97		1.0	0.99	0.9	0.84	0.73	0.89	0.99	0.77	0.58	0.9	0.99	0.86
Other Assets	0.93	0.99	-0.5	0.98	0.84	0.67	0.85	0.94	0.96	-0.88	0.98	0.49	0.95	1.0		0.99	0.92	0.87	0.75	0.9	0.99	0.78	0.58	0.91	0.99	0.83
Long Term Debt	0.93	1.0	-0.54	0.98	0.82	0.63	0.83	0.93	0.98	-0.88	0.98	0.43	0.95	0.99	0.99		0.92	0.85	0.74	0.92	1.0	0.78	0.57	0.91	1.0	0.83
Cash And Short Term Investments	1.0	0.92	-0.47	0.87	0.95	0.61	0.96	0.79	0.9	-0.73	0.87	0.52	0.81	0.9	0.92	0.92		0.88	0.68	0.99	0.92	0.74	0.59	0.92	0.91	0.62
Net Receivables	0.91	0.85	-0.26	0.83	0.83	0.83	0.79	0.7	0.84	-0.78	0.79	0.43	0.72	0.84	0.87	0.85	0.88		0.8	0.88	0.86	0.8	0.55	0.91	0.85	0.52
Common Stock Shares Outstanding	0.71	0.74	-0.21	0.73	0.52	0.66	0.54	0.64	0.72	-0.71	0.68	0.39	0.66	0.73	0.75	0.74	0.68	0.8		0.66	0.74	0.69	0.57	0.72	0.74	0.5
Short Term Investments	0.99	0.92	-0.47	0.87	0.92	0.59	0.92	0.78	0.93	-0.75	0.87	0.39	0.8	0.89	0.9	0.92	0.99	0.88	0.66		0.92	0.76	0.58	0.92	0.91	0.62
Non Current Liabilities Total	0.93	1.0	-0.53	0.98	0.82	0.64	0.83	0.94	0.98	-0.88	0.98	0.44	0.95	0.99	0.99	1.0	0.92	0.86	0.74	0.92		0.79	0.57	0.91	1.0	0.83
Inventory	0.78	0.78	-0.16	0.81	0.59	0.75	0.65	0.75	0.81	-0.93	0.76	0.22	0.76	0.77	0.78	0.78	0.74	0.8	0.69	0.76	0.79		0.62	0.93	0.79	0.72
Other Current Assets	0.61	0.57	0.22	0.54	0.56	0.57	0.61	0.5	0.55	-0.56	0.52	0.33	0.51	0.58	0.58	0.57	0.59	0.55	0.57	0.58	0.57	0.62		0.64	0.57	0.48
Other Stockholder Equity	0.94	0.91	-0.35	0.91	0.81	0.75	0.85	0.84	0.91	-0.92	0.88	0.4	0.86	0.9	0.91	0.91	0.92	0.91	0.72	0.92	0.91	0.93	0.64		0.92	0.74
Total Liab	0.92	1.0	-0.54	0.99	0.81	0.64	0.83	0.95	0.98	-0.89	0.99	0.44	0.96	0.99	0.99	1.0	0.91	0.85	0.74	0.91	1.0	0.79	0.57	0.92		0.84
Property Plant And Equipment Gross	0.64	0.83	-0.53	0.89	0.5	0.4	0.59	0.96	0.79	-0.88	0.9	0.32	0.95	0.86	0.83	0.83	0.62	0.52	0.5	0.62	0.83	0.72	0.48	0.74	0.84

Click cells to compare fundamentals

Novocure Account Relationship Matchups

Novocure fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	479.4M	1.1B	1.1B	1.2B	1.1B	651.0M
Short Long Term Debt Total	163.6M	444.2M	575.2M	584.3M	596.2M	626.1M
Other Current Liab	(1K)	35.7M	(17.8M)	(18.0M)	(16.2M)	(15.4M)
Total Current Liabilities	86.3M	113.6M	142.6M	158.8M	179.1M	188.1M
Total Stockholder Equity	217.8M	476.5M	410.5M	441.2M	362.5M	279.7M
Other Liab	11.7M	17.6M	11.2M	7.4M	8.5M	8.8M
Net Tangible Assets	217.8M	476.5M	410.5M	441.2M	507.3M	267.8M
Property Plant And Equipment Net	34.6M	41.6M	53.9M	69.0M	97.7M	102.6M
Net Debt	(13.8M)	209.5M	366.4M	468.9M	355.4M	373.2M
Retained Earnings	(650.9M)	(631.1M)	(685.9M)	(778.5M)	(985.5M)	(936.2M)
Accounts Payable	36.9M	53.6M	72.6M	85.2M	94.4M	99.1M
Cash	177.3M	234.7M	208.8M	115.3M	240.8M	164.9M
Non Current Assets Total	39.5M	52.5M	66.0M	80.1M	111.7M	117.3M
Non Currrent Assets Other	4.9M	10.9M	12.1M	11.2M	14.0M	14.7M
Other Assets	4.9M	10.9M	12.1M	11.2M	12.8M	13.5M
Long Term Debt	149.4M	429.9M	562.2M	565.5M	568.8M	597.3M
Cash And Short Term Investments	326.1M	842.6M	937.7M	969.4M	910.6M	518.3M
Net Receivables	88.1M	117.9M	110.6M	112.2M	77.1M	63.0M
Common Stock Shares Outstanding	97.2M	108.9M	103.4M	104.7M	106.4M	96.1M
Short Term Investments	148.8M	607.9M	728.9M	854.1M	669.8M	353.5M
Liabilities And Stockholders Equity	479.4M	1.1B	1.1B	1.2B	1.1B	651.0M
Non Current Liabilities Total	175.3M	461.8M	586.4M	591.7M	604.5M	634.7M
Inventory	23.7M	27.4M	24.4M	29.4M	38.2M	23.2M
Other Current Assets	1K	11.5M	807K	6.7M	8.5M	4.5M
Other Stockholder Equity	871.4M	1.1B	1.1B	1.2B	1.4B	916.6M
Total Liab	261.7M	575.5M	729.0M	750.5M	783.6M	822.8M
Total Current Assets	439.9M	999.4M	1.1B	1.1B	1.0B	607.6M
Accumulated Other Comprehensive Income	(2.8M)	(3.8M)	(3.2M)	(2.4M)	(5.5M)	(5.2M)
Property Plant Equipment	34.6M	11.4M	53.9M	32.7M	37.6M	22.9M
Retained Earnings Total Equity	(650.9M)	(631.1M)	(685.9M)	(778.5M)	(700.6M)	(735.6M)
Current Deferred Revenue	11.8M	17.8M	17.8M	18.0M	16.2M	13.4M
Long Term Debt Total	149.5M	429.9M	562.2M	565.5M	650.3M	682.9M
Capital Surpluse	871.4M	1.1B	1.1B	1.2B	1.4B	1.0B
Non Current Liabilities Other	182K	31.9M	166K	148K	18K	17.1K
Net Invested Capital	367.2M	906.4M	972.7M	1.0B	931.3M	731.9M
Net Working Capital	353.6M	885.8M	930.9M	952.8M	855.3M	696.2M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Novocure is a strong investment it is important to analyze Novocure's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Novocure's future performance. For an informed investment choice regarding Novocure Stock, refer to the following important reports:

How To Invest In Novocure

Details

Is Novocure Stock a good investment?

Details

What is Novocure's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novocure. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Novocure Stock, please use our How to Invest in Novocure guide.

Note that the Novocure information on this page should be used as a complementary analysis to other Novocure's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Complementary Tools for Novocure Stock analysis

When running Novocure's price analysis, check to measure Novocure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novocure is operating at the current time. Most of Novocure's value examination focuses on studying past and present price action to predict the probability of Novocure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novocure's price. Additionally, you may evaluate how the addition of Novocure to your portfolios can decrease your overall portfolio volatility.

	Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
	Bonds Directory Find actively traded corporate debentures issued by US companies
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets
	FinTech Suite Use AI to screen and filter profitable investment opportunities
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Technical Analysis Check basic technical indicators and analysis based on most latest market data
	Insider Screener Find insiders across different sectors to evaluate their impact on performance

Is Novocure's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novocure. If investors know Novocure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novocure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.06)

Earnings Share

(1.81)

Revenue Per Share

4.922

Quarterly Revenue Growth

0.134

Return On Assets

(0.11)

The market value of Novocure is measured differently than its book value, which is the value of Novocure that is recorded on the company's balance sheet. Investors also form their own opinion of Novocure's value that differs from its market value or its book value, called intrinsic value, which is Novocure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novocure's market value can be influenced by many factors that don't directly affect Novocure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Novocure's value and its price as these two are different measures arrived at by different means. Investors typically determine if Novocure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novocure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Novocure Other Operating Expenses vs Income Tax Expense Analysis

Other Operating Expenses vs Income Tax Expense

Other Operating Expenses vs Income Tax Expense Correlation Analysis

Correlation Coefficient

Other Operating Expenses

Income Tax Expense

Novocure fundamental ratios Correlations

Novocure Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Novocure fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Novocure Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Long Term Debt	+ 1.0	Short Long Term Debt Total
Non Current Liabilities Total	+ 1.0	Short Long Term Debt Total
Total Liab	+ 1.0	Short Long Term Debt Total
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Other Assets	+ 1.0	Non Currrent Assets Other

Inventory	- 0.93	Retained Earnings
Retained Earnings	- 0.93	Total Current Liabilities
Other Stockholder Equity	- 0.92	Retained Earnings
Non Current Assets Total	- 0.91	Retained Earnings
Retained Earnings	- 0.9	Property Plant And Equipment Net
Total Liab	- 0.89	Retained Earnings